Muñoz A - Search Results

1

Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.

Cicero TJ, Inciardi JA, Muñoz A. Cicero TJ, et al. Among authors: munoz a. J Pain. 2005 Oct;6(10):662-72. doi: 10.1016/j.jpain.2005.05.004. J Pain. 2005. PMID: 16202959

2

Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004.

Cicero TJ, Inciardi JA, Adams EH, Geller A, Senay EC, Woody GE, Muñoz A. Cicero TJ, et al. Among authors: munoz a. Pharmacoepidemiol Drug Saf. 2005 Dec;14(12):851-9. doi: 10.1002/pds.1113. Pharmacoepidemiol Drug Saf. 2005. PMID: 15892169

3

Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010.

Severtson SG, Bartelson BB, Davis JM, Muñoz A, Schneider MF, Chilcoat H, Coplan PM, Surratt H, Dart RC. Severtson SG, et al. Among authors: munoz a. J Pain. 2013 Oct;14(10):1122-30. doi: 10.1016/j.jpain.2013.04.011. Epub 2013 Jun 29. J Pain. 2013. PMID: 23816949

4

Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007.

Schneider MF, Bailey JE, Cicero TJ, Dart RC, Inciardi JA, Parrino M, Muñoz A. Schneider MF, et al. Among authors: munoz a. Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):778-90. doi: 10.1002/pds.1780. Pharmacoepidemiol Drug Saf. 2009. PMID: 19536784

5

Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.

Cicero TJ, Surratt H, Inciardi JA, Munoz A. Cicero TJ, et al. Among authors: munoz a. Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):827-40. doi: 10.1002/pds.1452. Pharmacoepidemiol Drug Saf. 2007. PMID: 17636553

6

The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).

Cicero TJ, Dart RC, Inciardi JA, Woody GE, Schnoll S, Muñoz A. Cicero TJ, et al. Among authors: munoz a. Pain Med. 2007 Mar;8(2):157-70. doi: 10.1111/j.1526-4637.2006.00259.x. Pain Med. 2007. PMID: 17305687

7

A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States.

Cicero TJ, Adams EH, Geller A, Inciardi JA, Muñoz A, Schnoll SH, Senay EC, Woody GE. Cicero TJ, et al. Among authors: munoz a. Drug Alcohol Depend. 1999 Nov 1;57(1):7-22. doi: 10.1016/s0376-8716(99)00041-1. Drug Alcohol Depend. 1999. PMID: 10617309

8

The Diversion of Ultram, Ultracet, and generic tramadol HCL.

Inciardi JA, Cicero TJ, Munoz A, Adams EH, Geller A, Senay EC, Woody GE. Inciardi JA, et al. Among authors: munoz a. J Addict Dis. 2006;25(2):53-8. doi: 10.1300/J069v25n02_08. J Addict Dis. 2006. PMID: 16785220

9

Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur.

Senay EC, Adams EH, Geller A, Inciardi JA, Muñoz A, Schnoll SH, Woody GE, Cicero TJ. Senay EC, et al. Among authors: munoz a. Drug Alcohol Depend. 2003 Apr 1;69(3):233-41. doi: 10.1016/s0376-8716(02)00321-6. Drug Alcohol Depend. 2003. PMID: 12633909

10

An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride).

Woody GE, Senay EC, Geller A, Adams EH, Inciardi JA, Schnoll S, Muñoz A, Cicero TJ. Woody GE, et al. Among authors: munoz a. Drug Alcohol Depend. 2003 Nov 24;72(2):163-8. doi: 10.1016/s0376-8716(03)00198-4. Drug Alcohol Depend. 2003. PMID: 14636971

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results